Free Trial
→ China just unlocked Nvidia’s AI chips—what that means for you (From Timothy Sykes) (Ad) Free ATHE Stock Alerts

Alterity Therapeutics (ATHE) SEC Filings & 10K Form

Alterity Therapeutics logo
$5.01 -0.05 (-0.99%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$4.99 -0.02 (-0.50%)
As of 08/1/2025 07:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Alterity Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
07/30/2025
8:39 PM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2025
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/28/2025
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/28/2025
7:02 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/21/2025
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/17/2025
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/14/2025
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/07/2025
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/03/2025
5:39 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/30/2025
5:14 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/23/2025
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2025
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/12/2025
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/12/2025
7:01 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2025
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/05/2025
1:03 PM		ALTERITY THERAPEUTICS LTD (Subject)
Alterity Therapeutics (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Form SCHEDULE 13G/A
05/05/2025
5:17 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/02/2025
8:59 AM		ALTERITY THERAPEUTICS LTD (Subject)
Alterity Therapeutics (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Form SCHEDULE 13G
04/30/2025
7:05 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2025
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/28/2025
7:01 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/17/2025
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/10/2025
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/09/2025
8:47 PM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/09/2025
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2025
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/07/2025
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/07/2025
7:01 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/07/2025
7:02 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/31/2025
7:31 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2025
5:13 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/25/2025
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/14/2025
6:32 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/14/2025
5:50 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/28/2025
6:59 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/28/2025
6:01 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/24/2025
5:08 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/19/2025
5:56 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2025
7:13 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2025
6:59 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/10/2025
6:25 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
This rock I’m holding could be worth trillions (Ad)

A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems. While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone.

See the name and ticker behind America’s $16 trillion resource push.
02/10/2025
6:17 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/06/2025
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/06/2025
7:01 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/05/2025
5:33 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/04/2025
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/30/2025
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/30/2025
7:02 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/28/2025
5:33 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/24/2025
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/22/2025
7:02 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/21/2025
5:35 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/06/2025
7:05 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/31/2024
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/04/2024
6:35 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/22/2024
5:58 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/22/2024
6:10 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/22/2024
6:14 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/19/2024
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/12/2024
5:27 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/05/2024
7:00 PM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2024
7:48 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/23/2024
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/10/2024
8:15 PM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/04/2024
5:26 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/02/2024
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/30/2024
5:20 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/26/2024
3:30 PM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/26/2024
3:32 PM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/26/2024
3:33 PM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/26/2024
3:40 PM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
09/23/2024
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2024
7:00 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/03/2024
5:03 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/29/2024
5:07 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/01/2024
6:06 AM		ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ATHE) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...
Brownstone Research | Sponsored
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsored
Man Who Called Nvidia at $1.10 Says Buy This Now...
In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...
The Oxford Club | Sponsored
Jeff Bezos Launches "ChatGPT Killer"?
Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...
Stansberry Research | Sponsored
Alien rocks potentially worth trillions…
It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...
Porter & Company | Sponsored
[No Brainer Gold Play]: “Show me a better investment.”
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...
Golden Portfolio | Sponsored
Too busy to trade? Good.
Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...
Timothy Sykes | Sponsored
This Social Security Shift Could Boost Benefits by 400%
If you currently collect Social Security—or plan to in the future—this may be one of the most important update...
InvestorPlace | Sponsored